Goldman Sachs Group Cuts Stake in Puma Biotechnology (PBYI)
PumaBiotech (@pumabiotech) / X
Praneeth C. - Clinical Data Management - Puma Biotechnology, Inc. | LinkedIn
Puma Biotechnology Announces FDA Clearance of IND for Alisertib in Small Cell Lung Cancer | Business Wire
Puma Biotechnology Reports Results of PB272 (neratinib) in P-III NALA Trial for Patients with 2L+ HER2+ Metastatic Breast Cancer #ASCO2019
Former Puma Biotechnology Executive Sentenced to More than Two Years in Prison for Insider Trading | BioSpace
Puma Biotechnology, Inc. - SEC Filings - Annual Reports & Proxies
PUMA BIOTECHNOLOGY, INC. FORM 8-K/A - Shareholder.com
Why Puma Biotechnology (PBYI) Stock Is Surging Today - TheStreet
Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so | Fierce Pharma
Puma Biotechnology lung cancer candidate IND cleared by FDA | Seeking Alpha
Articles about Puma Biotechnology | page 6
Is Puma Biotechnology (PBYI) Stock a Solid Choice Right Now?
Puma Biotechnology, Inc. (NASD:PBYI) Seasonal Chart | Equity Clock
Price-Forecasting Models for Puma Biotechnology PBYI Stock : Ta, Ton Viet: Amazon.sg: Books
Puma Biotechnology Reports Second Quarter Financial Results | Business Wire
Puma Biotechnology, Inc. (PBYI) Price, Charts, Market Cap, Markets, Exchanges, PBYI to USD Calculator
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | citybiz
Puma Biotechnology, Inc. (Puma Biotechnology) Stock Price & News | PBYI
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
Dennis Sanders - Senior Clinical Specialist - Puma Biotechnology, Inc. | LinkedIn
